Entering text into the input field will update the search result below

Sunesis +1.9% on $15.5M repurchase agreement

Jun. 25, 2018 4:46 PM ETViracta Therapeutics, Inc. (VIRX) StockBy: Brandy Betz, SA News Editor
  • Sunesis Pharmaceuticals (SNSS) enters a repurchase program of up to $15.5M shares with Aspire Capital Fund.
  • Under the agreement, Aspire Capital has made an initial investment by purchasing $500K worth of common shares at $2.19/share.
  • Aspire Capital commits to purchasing up to an additional $15M of common shares at the request of Sunesis during a 24-month period. 
  • Sunesis Pharmaceuticals shares are up 1.9% aftermarket to $2.15.  

Recommended For You

More Trending News

About VIRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VIRX--
Viracta Therapeutics, Inc.